1107 related articles for article (PubMed ID: 9079268)
41. Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers.
Savarino E; Zentilin P; Frazzoni M; Cuoco DL; Pohl D; Dulbecco P; Marabotto E; Sammito G; Gemignani L; Tutuian R; Savarino V
Neurogastroenterol Motil; 2010 Oct; 22(10):1061-e280. PubMed ID: 20557468
[TBL] [Abstract][Full Text] [Related]
42. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
Brandt MG; Darling GE; Miller L
Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux.
Koufman JA; Belafsky PC; Bach KK; Daniel E; Postma GN
Laryngoscope; 2002 Sep; 112(9):1606-9. PubMed ID: 12352672
[TBL] [Abstract][Full Text] [Related]
44. Functional foregut abnormalities in Barrett's esophagus.
Stein HJ; Hoeft S; DeMeester TR
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):107-11. PubMed ID: 8419690
[TBL] [Abstract][Full Text] [Related]
45. Gastric surgery does not increase the risk of developing Barrett's esophagus.
Parrilla P; Liron R; Martinez de Haro LF; Ortiz A; Molina J; De Andrés B
Am J Gastroenterol; 1997 Jun; 92(6):960-3. PubMed ID: 9177510
[TBL] [Abstract][Full Text] [Related]
46. Barrett's esophagus and the presence of Helicobacter pylori.
Henihan RD; Stuart RC; Nolan N; Gorey TF; Hennessy TP; O'Morain CA
Am J Gastroenterol; 1998 Apr; 93(4):542-6. PubMed ID: 9576445
[TBL] [Abstract][Full Text] [Related]
47. Length of the esophagus in patients with gastroesophageal reflux disease and Barrett's esophagus compared to controls.
Korn O; Csendes A; Burdiles P; Braghetto I; Sagastume H; Biagini L
Surgery; 2003 Apr; 133(4):358-63. PubMed ID: 12717351
[TBL] [Abstract][Full Text] [Related]
48. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.
Peng S; Cui Y; Xiao YL; Xiong LS; Hu PJ; Li CJ; Chen MH
Endoscopy; 2009 Dec; 41(12):1011-7. PubMed ID: 19967617
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
[TBL] [Abstract][Full Text] [Related]
52. Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats.
Cheng P; Gong J; Wang T; Jie C; Liu GS; Zhang R
World J Gastroenterol; 2005 Jun; 11(21):3277-80. PubMed ID: 15929182
[TBL] [Abstract][Full Text] [Related]
53. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
De Backer AI; De Schepper AM; Pelckmans P
Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
[TBL] [Abstract][Full Text] [Related]
54. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.
Orlando RC
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):873-82. PubMed ID: 21126700
[TBL] [Abstract][Full Text] [Related]
55. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
[TBL] [Abstract][Full Text] [Related]
56. [Barrett's esophagus, gastroesophageal acid reflux and duodenogastric reflux during the digestive and postprandial period].
Li V; Bost R; Caravel JP; Fournet J; Hostein J
Gastroenterol Clin Biol; 1992; 16(12):978-83. PubMed ID: 1493899
[TBL] [Abstract][Full Text] [Related]
57. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
58. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
59. [Barret's esophagus and acid gastroesophageal reflux. Two-channel pH-metric measurements and manometric study].
Bruley des Varannes S; Ravenbakht-Charifi M; Cloarec D; Pujol P; Simon J; Galmiche JP
Gastroenterol Clin Biol; 1992; 16(5):406-12. PubMed ID: 1526394
[TBL] [Abstract][Full Text] [Related]
60. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
